Clinical Trials in Miami

Showing 3501-3520 of 9,821 trials

Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment

NCT04480827

Phase 1, multicenter, open-label, 2-part, single- and multiple-dose study designed to assess the effect of hepatic insufficiency on the PK of aramchol

Hepatic Impairment

Galmed Research and Development, Ltd.57 participantsStarted Feb 2020

Miami, Florida, United States • Orlando, Florida, United States • Knoxville, Tennessee, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT03985943

The main purpose of the study was to assess the efficacy and safety of nemolizumab after a 16-week treatment period in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical treatments.

Moderate-to-Severe Atopic Dermatitis

Galderma R&D941 participantsStarted Jun 2019

North Little Rock, Arkansas, United States • Cerritos, California, United States • Fountain Valley, California, United States +171 more locations

Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Find Trials by Condition in Miami

Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Trial to Assess Chelation Therapy in Critical Limb Ischemia

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

Study of OMNI System in OAG (GEMINI)

Physiologic Pacing Registry

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)